Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Dimas, CA
NPI
1861423709
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
615 E Foothill Blvd Ste C
San Dimas, CA, 91773
Phone (626) 335-8094
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
2,222 services
Medicare patients, 2024
376
Average age 74
Drug cost, 2024
$3.4M
8,832 prescriptions
Company payments, 2025
$3,196
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc Gutin was code 82962 (clinical chemistry), 697 times for 263 patients. In total Marc Gutin billed 2,222 services in 11 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 697 | 263 | $3.21 | $2,235 |
| 99213 Office E&M - Established | Office | 668 | 286 | $66.86 | $45K |
| 95251 Test - Miscellaneous | Office | 363 | 132 | $27.03 | $9,812 |
| 99214 Office E&M - Established | Office | 300 | 224 | $99.28 | $30K |
| 83036 Blood Count | Office | 121 | 99 | $9.52 | $1,152 |
| 99205 Office E&M - New | Office | 42 | 42 | $162.94 | $6,843 |
| 95250 Test - Miscellaneous | Office | 21 | 19 | $123.21 | $2,587 |
By year: 2022 $101K for 2,572 services; 2023 $95K for 2,249 services; 2024 $98K for 2,222 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 697 | 263 | $3.21 | $2,235 |
| 83036 Blood Count | 121 | 99 | $9.52 | $1,152 |
Medicare prescription drug claims, 2024
In 2024, the drug Marc Gutin prescribed most often to Medicare patients was Ozempic (Semaglutide), with 648 prescriptions and refills. In total Marc Gutin wrote 8,832 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 648 | 894 | 141 | $824K |
| Metformin Hcl Generic | 628 | 1,643 | 190 | $5,548 |
| Levothyroxine Sodium Generic | 558 | 1,397 | 167 | $5,861 |
| Losartan Potassium Generic | 266 | 697 | 76 | $2,505 |
| Atorvastatin Calcium Generic | 241 | 642 | 78 | $2,072 |
| Jardiance Empagliflozin | 231 | 489 | 81 | $279K |
| Amlodipine Besylate Generic | 188 | 498 | 56 | $900 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 178 | 477 | 85 | $20K |
| Synthroid Levothyroxine Sodium | 172 | 440 | 45 | $16K |
| Mounjaro Tirzepatide | 160 | 182 | 48 | $185K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 149 | 321 | 49 | $22K |
| Simvastatin Generic | 143 | 361 | 43 | $1,144 |
| Rosuvastatin Calcium Generic | 129 | 295 | 38 | $1,326 |
| Afrezza Insulin Regular, Human | 126 | 197 | 24 | $222K |
| Rybelsus Semaglutide | 124 | 216 | 37 | $195K |
Brand drugs: 3,730 claims; generic drugs: 4,635 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc Gutin $3,196 ($3,196 in general payments such as food, travel and fees) from 26 companies. The largest payer was Medtronic, Inc. with $573.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.